ETHICON INC. SURGICEL FIBRILLAR 1INX2IN(2.5CMX5.1CM); AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED
|
Back to Search Results |
|
Model Number 411961 |
Device Problem
Device Markings/Labelling Problem (2911)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/10/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
Product complaint #: (b)(4).To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Additional information was requested, and the following was obtained: please clarify if the event mentioned was previously reported to ethicon? if so, provide the respective reference number(s).No event reported previously to j&j romania, as they seem to have confirmed by themselves that the product was compliant.Did the outer package show any signs of damaged when received? was the package properly sealed when received? as per pictures received there does not seem to be any issue, and the distributor did not complain about any kind of damage, only the missing ec rep on the outer box details.Please clarify, if is a local label missing from the packing? no, it's not a local label that is missing.The data is missing from the original packaging.As per pictures, the ec rep data is not visible on the outer packaging and labeling.In previous version carton (this data was visible on a side of the packaging).Please clarify quantity involved? a: 2 boxes of code: 411961, lot#: qdb3991.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
|
|
Event Description
|
It was reported that at the compliance checks of the products received on (b)(6) 2020 in the warehouse, it was discovered that 2 boxes of absorbable hemostat, did not bear the ec rep details.No adverse patient consequences were reported.Additional information was requested.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Date sent to the fda: 12/29/20.Investigation summary => three photos were received for analysis.A review of european medical device directive (mdd) and manufacturing specifications from san lorenzo confirmed that the product was manufactured according to specifications and the product meets the ce-mark requirements.Per the european medical device directive (mdd) requirements, the authorized representative information must appear on the product label or the outer packaging or the instructions for use.For surgicel fibrillar, the authorized representative is printed on the outer-package (the carton tray), the product label (the sterile barrier), and on the instructions for use.While the carton sleeve covers the authorized representative information and must be slid forward or back to reveal the information printed on the side of the carton tray, the carton tray and sleeve are two components of the outer-package and still meets the mdd requirements.Based the investigation, the complaint is not confirmed.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Search Alerts/Recalls
|
|
|